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Abstract
AIM: To examine the relevance of hypoxia inducible 
factor (HIF-1) and nitric oxide (NO) on the preserva-
tion of fatty liver against cold ischemia-reperfusion 
injury (IRI).
METHODS: We used an isolated perfused rat liver mod-
el and we evaluated HIF-1α in steatotic and non-stea-
totic livers preserved for 24 h at 4℃ in University of Wis-
consin and IGL-1 solutions, and then subjected to 2 h 
of normothermic reperfusion. After normoxic reperfu-
sion, liver enzymes, bile production, bromosulfophtha-
lein clearance, as well as HIF-1α and NO [endothelial 
NO synthase (eNOS) activity and nitrites/nitrates] were 
also measured. Other factors associated with the higher 
susceptibility of steatotic livers to IRI, such as mitochon-
drial damage and vascular resistance were evaluated. 
RESULTS: A significant increase in HIF-1α was found 
in steatotic and non-steatotic livers preserved in IGL-1 
after cold storage. Livers preserved in IGL-1 showed 
a significant attenuation of liver injury and improve-
ment in liver function parameters. These benefits were 
enhanced by the addition of trimetazidine (an anti-
ischemic drug), which induces NO and eNOS activation, 
to IGL-1 solution. In normoxic reperfusion, the presence 
of NO favors HIF-1α accumulation, promoting also the 
activation of other cytoprotective genes, such as heme-
oxygenase-1. 
CONCLUSION: We found evidence for the role of the 
HIF-1α/NO system in fatty liver preservation, especially 
when IGL-1 solution is used.
© 2010 Baishideng. All rights reserved.
Key words: Fatty liver; Tissue preservation; Hypoxia in-
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INTRODUCTION
During the last decade, the dramatic shortage of  organs 
has obliged physicians to consider the transplantation 
of  liver grafts with moderate steatosis[1-3]. Liver steatosis 
results from the abnormal accumulation of  fat in the 
cytoplasm of  hepatocytes. This causes alterations in the 
microcirculation with a higher risk of  graft dysfunction 
or primary nonfunction. Steatotic liver grafts thus show 
poor tolerance to ischemia-reperfusion injury (IRI) as-
sociated with transplantation[3-5]. The composition of  
preservation solutions is critical for the quality of  liver 
grafts during cold ischemia. Although University Wis-
consin solution (UW) is the gold standard for abdominal 
organs, its use has been questioned because it contains 
hydroxyl-ethyl starch (HES), and a high concentration 
of  K+ ions[6-9]. It is has been reported that HES could be 
responsible for red blood cell aggregation[10-12].
Recently, IGL-1 solution has been proposed as an ef-
fective alternative to UW for steatotic liver preservation[12]. 
It has a lower concentration of  K+ ions and contains 
polyethylene glycol as osmotic support instead of  HES. 
The benefits of  IGL-1 are due in part to its capacity to 
increase the levels of  nitric oxide (NO)[12], which protects 
the liver against IRI[13], and thus mitigates the alterations 
to hepatic microcirculation[12].
Cold ischemia graft preservation is characterized by 
a lack of  oxygen supply to the liver. In these conditions, 
hypoxia inducible factor 1 (HIF-1) regulates the adap-
tive response of  the organ to the changes in oxygenation 
induced during preservation[14]. HIF-1 is a heterodimer 
formed by α and β subunits which are constitutively ex-
pressed. The β subunit is independent of  O2, whereas the 
protein stability of  the α subunit depends on the cellular 
levels of  O2[15]. Under normoxic conditions, the α subunit 
is degraded by a complex process involving the prolyl-
hydroxylases, the Von Hippel Landau protein and the 26 
S proteasomes[15,16]. It is well established that NO impairs 
normoxic degradation of  HIF-1α by inhibition of  HIF-1 
prolyl-hydroxylases and contributes to its stabilization[17]. 
HIF-1α confers protection against IRI by activating 
others genes such as heme oxygenase-1 (HO-1)[18-20] which 
plays an important cytoprotective role in liver graft preser-
vation against cold IRI[21,22]. 
Recently, it has been demonstrated that anti ischemic 
drugs such as trimetazidine (TMZ) protect heart mes-
enchymal stem cells against hypoxic insult by increasing 
HIF-1α expression[23]. Similar results were reported by 
Jayle et al[14] in TMZ-treated pig kidneys subjected to warm 
IRI. In addition, the benefits of  TMZ seem to be associ-
ated with its capacity to generate NO[24] and the activation 
of  endothelial NO synthase (eNOS) when it was used as 
an additive in UW solution[25].
As HIF-1α is involved in cell survival during IRI, we 
examined how hypoxic adaptations can be exploited to 
protect fatty livers in preservation solutions. We hypoth-
esized that the HIF-1α accumulation during cold ischemia 
would be hepato-protective in normoxic reperfusion as a 
result of  the NO-stabilizing action induced by IGL-1.
To test this hypothesis, we added TMZ to IGL-1 solu-
tion, and examined the effects of  various protocols on the 
preservation of  livers excised from rats. We found that the 
addition of  TMZ to IGL-1 solution has a synergistic ef-
fect on NO generation and thus favors HIF-1α accumula-
tion during normothermic reperfusion. Preserved HIF-1α 
levels contribute to the increase in the over-expression of  
HO-1 in fatty liver grafts.
The results reported here reveal the importance of  the 
HIF-1α/NO system in the prevention of  liver cold IRI, 
especially when moderate steatosis is present.
MATERIALS AND METHODS
Homozygous obese (Ob) Zucker rats and heterozygous 
lean (Ln) Zucker rats (reference group), aged 16-18 wk, 
were obtained from Iffa-Credo (L’Abresle, France)[12,25].
An isolated perfused rat liver model was used to evalu-
ate hepatic function separate from the influence of  other 
organ systems, undefined plasma constituents, and neu-
ral/hormonal effects. Hepatic architecture, microcircula-
tion, and bile production are preserved in this experi-
mental model[26,27]. All procedures were performed under 
isoflurane inhalation anesthesia. This study adhered to 
European Union regulations (Directive 86/609/CEE) for 
animal experiments. 
Liver procurement and experimental groups
The surgical technique was performed as described else-
where[12,28]. After cannulation of  the common bile duct, 
the portal vein was isolated and the splenic and gastro-
duodenal veins were ligated. All animals were randomly 
distributed into groups as described below.
Protocol Ⅰ:  induction of  HIF-1α  in steatotic  livers 
after  24 h of   cold  ischemia  in  IGL-1 preservation 
solution:  In order to evaluate the potential generation 
of  HIF-1α during liver graft storage (24 h, 4℃) in IGL-1 
preservation solution, and the benefits of  the addition 
of  TMZ, the following experiments were carried out: 
(1) Cont 1: Control livers from 16 Zucker rats (8 Ln and 
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8 Ob) were flushed with Ringer’s lactate solution immedi-
ately after laparatomy via the portal vein without cold stor-
age; (2) UW: Livers from 16 Zucker rats (8 Ln and 8 Ob) 
were preserved for 24 h in UW solution; (3) IGL-1: Livers 
from 16 Zucker rats (8 Ln and 8 Ob) were preserved for 
24 h in IGL-1 solution; and (4) IGL-1 + TMZ: Livers 
from 16 Zucker rats (8 Ln and 8 Ob) were preserved for 
24 h in IGL-1 with TMZ at a concentration of  10-6 mol/L, 
as previously described[25,28]. 
Aliquots of  the effluent flush corresponding to groups 
1, 2, 3 and 4 were sampled for measurements of  cumula-
tive transaminases. Liver tissue samples were used for 
HIF-1α activity determination after prolonged ischemia. 
Protocol Ⅱ:  effect of  NO on HIF-1α  stabilization 
and HO-1  induction after  cold  IRI: To examine the 
role of  NO in stabilizing HIF-1α formed during cold 
ischemia, and the subsequent effect on HO-1 generation, 
fatty livers were subjected to 2 h-normoxic reperfusion, 
in the following groups: (5) Cont 2: Control livers from 16 
Zucker rats (8 Ln and 8 Ob) were flushed with Ringer’s 
lactate and immediately perfused ex vivo without ischemic 
preservation; (6) UW: Livers from 16 Zucker rats (8 Ln 
and 8 Ob) were preserved for 24 h in UW solution and 
then inserted into an isolated perfused rat liver system for 
2 h; (7) IGL-1: Livers from 16 Zucker rats (8 Ln and 8 
Ob) were preserved in IGL-1 solution and then inserted 
into an isolated perfused rat liver system for 2 h; (8) 
IGL-1 + TMZ: Livers from 16 Zucker rats (8 Ln and 8 
Ob) were preserved for 24 h in IGL-1 with the addition 
of  10-6 mol/L TMZ and then inserted into an isolated 
perfused rat liver system for 2 h[25,28]; and (9) IGL-1 + 
TMZ + NAME: Livers from 16 Zucker rats (8 Ln and 8 
Ob) were preserved for 24 h in IGL-1 with the addition 
of  10-6 mol/L TMZ and Nω-nitro-L-arginine methyl es-
ter hydrochloride (L-NAME), an inhibitor of  NO synthe-
sis, at a dose of  60 μg/g liver before cold ischemia, and 
then inserted into an isolated perfused rat liver system for 
2 h[28].
In order to account for the period of  rewarming dur-
ing surgical implantation in vivo[28], after 24 h of  cold pres-
ervation livers from groups 5, 6, 7, 8 and 9 (Protocol Ⅱ) 
were exposed to 22℃ for 30 min prior to reperfusion. 
Livers were then connected via the portal vein to a recir-
culating perfusion system for 120 min at 37℃[12,25]. Time 0 
was the point at which the portal catheter was connected 
to the circuit. As previously reported[12,28], during the first 
15 min of  perfusion (initial equilibration period), the 
flow was progressively increased in order to stabilize 
the portal pressure at 12 mmHg (Pression Monitor 
BP-1; Pression Instruments, Sarasota, FL, USA). The 
flow was controlled using a peristaltic pump (Minipuls 
3, Gilson, France)[12,25]. The reperfusion liquid consisted 
of  a cell culture medium (William’s medium E; Bio 
Whitaker, Barcelona, Spain) with a Krebs-Heinseleit-
like electrolyte composition enriched with 5% albumin 
osmotic support. The buffer was continuously venti-
lated with 95% O2 and 5% CO2 gas mixture. The buf-
fer was subsequently passed through a heat exchanger 
(37℃) and a bubble trap prior to entering the liver[25]. 
During 120 min of  normothermic reperfusion, the ef-
fluent was collected at 30-min intervals to measure liver 
transaminases. After the initial equilibration period of  
15 min, flow rate and vascular resistance were assessed 
continuously throughout the reperfusion. Bile output, 
hepatic clearance [expressed as percentage of  sulfobro-
mophthalein (BSP) in bile samples], HIF-1α activity, and 
NOS proteins were evaluated at 120 min of  reperfusion.
Biochemical determinations
Liver injury: Hepatic injury was evaluated according to 
transaminase levels using a commercial kit from Boeh-
ringer Mannheim (Munich, Germany).
Liver function: Liver function was assessed by measuring 
bile production[12,25]. Bile was collected through the cannu-
lated bile duct and output is reported as µL/g liver.
Hepatic clearance: As with bile output, hepatic clearance 
was considered as another parameter of  hepatic func-
tion[27,28]. Thirty minutes after the onset of  the perfusion 
(t30), 1 mg of  BSP (Sigma, Spain) was added to the perfus-
ate. The concentration of  BSP in bile samples (t120) was 
measured at 580 nm with a UV-visible spectrometer. Bile 
BSP excretion was expressed as a percentage of  perfusate 
content (t120 bile/t30 perfusate × 100)[28,29].
Vascular resistance: Liver circulation was assessed by 
measuring perfusion flow rate and vascular resistance[26,28]. 
Perfusion flow rate was assessed continuously throughout 
the reperfusion period and expressed as mL/min × g. 
Vascular resistance was defined as the ratio of  portal ve-
nous pressure to flow rate and expressed in mmHg × min 
× g/mL[26,28]. 
Glutamate dehydrogenase activity: Glutamate dehydro-
genase (GLDH) is a mitochondrial enzyme and was used as 
an indirect measure of  mitochondrial damage[25,28]. GLDH 
activity was determined in perfusates as described else-
where[25,28].
Determination of  nitrite and nitrate: NO production in 
liver was determined by tissue accumulation of  nitrite and 
nitrate, as previously reported[25,28].
eNOS immunohistochemistry: Frozen liver sections 
(18 μm thick) were fixed in pre-cooled acetone for 10 min 
at room temperature. After washing with phosphate-buff-
ered saline (PBS), permeabilization was performed with 
0.5% Triton X-100 for 15 min each. Antibody non-specif-
ic binding was blocked for 1 h in PBS with 10% normal 
goat serum, 3% bovine serum albumin, 1.5% NaCl and 
0.5% Triton X-100 for 1 h. The primary eNOS antibody 
(Polyclonal IgG anti-NOS-3, Santa Cruz Biotechnology, 
Santa Cruz, CA, USA) was applied at a dilution of  1:100 
in the blocking solution and incubated for 1 h at room 
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temperature in a moist chamber. After rinsing with PBS, 
permeabilization was performed again with 0.5% Triton 
X-100, 3 times for 10 min each. The secondary antibody 
goat anti-rabbit Alexa488 Fluor labeled (Invitrogen) was 
applied at a dilution of  1:400 in the blocking solution for 
50 min at room temperature. After washing with PBS, the 
slides were mounted with ProLong Gold antifade (with 
DAPI) mounting medium, and eNOS immunohistochem-
istry images were obtained by fluorescence microscope.
Western blottings of eNOS and HO-1
Liver tissue was homogenized as previously described[28] 
and proteins were separated by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis and transferred to poly-
vinylidene fluoride membranes. Membranes were immu-
noblotted with antibodies against anti-eNOS (transduction 
laboratories, Lexington, KY, USA), against anti-HO-1 
(Sigma Chemical, St Louis, MO, USA) and β-actin (Sigma 
Chemical, St. Louis, MO, USA). Signals were detected by 
enhanced chemiluminescence and quantified by scanning 
densitometry.
Preparation of  nuclear fraction: Nuclear fractions were 
prepared from frozen liver tissues which were suspended 
in a hypotonic buffer that contained 10 mmol/L HEPES 
(pH 7.6), 15 mmol/L KCl, 2 mmol/L MgCl2, 0.1 mmol/L 
EDTA, 1 mmol/L dithiothreitol, and 0.2% Nonidet P-40 
with protease inhibitor (1 mmol/L phenylmethylsulfo-
nyl fluoride, 1 μg/mL aprotinin, 1 μg/mL leupeptin and 
1 μg/mL pepstatin) and homogenized for 40 s with a poly-
tron homogenizer. After centrifugation at 850 g the super-
natant that contained cytoplasmic and membrane protein 
was collected. Nuclear proteins were extracted at 4℃ by 
gently resuspending the nuclear pellet in hypertonic buffer 
that contained 25 mmol/L HEPES (pH 7.8), 50 mmol/L 
KCl, 0.1 mmol/L EDTA, 1 mmol/L dithiothreitol, 10% 
glycerol, 0.4 mol/L NaCl and protease inhibitor, followed 
by 30 min incubation at 4℃ with occasional vortexing. 
After centrifugation at 18 000 g for 15 min at 4℃, the su-
pernatant that contained nuclear protein was collected and 
protein concentration was measured by the Bradford Pro-
tein method (Bio-Rad, Hercules, CA, USA).
HIF-1α measurement: HIF-1α translocation to nuclei 
was assessed by Western blotting and was also quantified 
by specific binding of  HIF-1α to its specific oligonucle-
otide recognition hypoxia responsive element, using the 
Trans AM HIF-1α kit (Active Motiv, Carlsbad, CA, USA). 
Membranes were incubated with an antibody against anti-
HIF-1α (Santa Cruz Biotechnology, Santa Cruz, CA, 
USA). Signals were detected by enhanced chemilumines-
cence and quantified by scanning densitometry. For the 
quantitative method, samples were run in duplicate in 
microtiter plates coated with an oligonucleotide for HIF-
1α following manufacturer’s instructions. Results are ex-
pressed as μg HIF-1α/mg protein of  nuclei extract[30,31]. 
Statistical analysis
Data are expressed as mean ± SE, and were compared 
statistically by variance analysis, followed by the Student-
Newman-Keuls test (Graph Pad Prism software). P < 
0.05 was considered significant.
RESULTS
Induction of HIF-1α in non-steatotic and steatotic livers 
after 24 h of cold ischemia
As indicated in Figure 1A and B, cumulative HIF-1α 
levels were determined in non-steatotic and steatotic liv-
ers preserved in IGL-1 + TMZ solutions and compared 
to levels observed in IGL-1 and UW alone. HIF-1α ac-
cumulation was significantly increased by the addition of  
TMZ to IGL-1 solution in both types of  liver. Although 
steatotic livers showed slightly lower HIF-1α levels than 
non-steatotic livers, these differences were not significant 
(Figure 1A and B). 
Liver ischemic damage was assessed by alanine trans-
aminase (ALT) and aspartate transaminase (AST) levels 
after 24 h of  cold storage as shown in Figure 1C and D. A 
significant reduction in release of  ALT and AST occurred 
in non-steatotic and steatotic livers preserved in IGL-1 
+ TMZ when compared to IGL-1 and UW, respectively. 
This reduction correlated with the significant accumula-
tion of  HIF-1α observed for the IGL-1 + TMZ and 
IGL-1 solutions (Figure 1A and B).
Stabilization of HIF-1α in non-steatotic and steatotic 
livers after cold ischemia-reperfusion: role of NO
In order to evaluate whether HIF-1α could be stabilized 
by NO after hepatic reperfusion, we measured HIF-1α 
accumulation in steatotic and non-steatotic livers pre-
served in UW, IGL-1 and IGL-1 + TMZ solutions (24 h, 
4℃) and then subjected to 2 h normoxic reperfusion (37℃). 
NO generation was inhibited by the addition of  L-NAME 
to IGL-1 + TMZ solution (IGL-1 + TMZ + NAME).
Figure 2 shows the HIF-1α levels after 2 h of  normo-
thermic reperfusion in steatotic and non-steatotic livers 
preserved in IGL-1, IGL-1 + TMZ and UW solutions, re-
spectively. HIF-1α levels were higher in the non-steatotic 
and steatotic livers stored in IGL-1 + TMZ solution than 
in those stored in IGL-1 and UW respectively. In all cases, 
the greatest increases were for the non-steatotic and stea-
totic livers preserved in IGL-1 enriched with TMZ (IGL 
+ TMZ), and were significantly prevented by L-NAME 
(Figure 2A and B). 
eNOS activity and nitrite/nitrate levels were higher 
in the steatotic and non-steatotic livers preserved in 
IGL-1 + TMZ when compared to UW and IGL-1 alone 
(Figure 2C, D and Figure 3). This enhanced eNOS activity 
and nitrite/nitrate levels were more evident when TMZ 
was added to IGL-1. In contrast, the addition of  L-NAME 
to IGL-1 + TMZ solution reduced both.
In order to evaluate the benefits of  HIF-1α and NO 
in livers preserved in IGL-1 and IGL-1 + TMZ after 
reperfusion, we evaluated liver injury (AST/ALT) and 
function (bile production, vascular resistance), as indi-
cated in Figure 4.
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At 2 h reperfusion release of  ALT and AST was signif-
icantly lower in non-steatotic and steatotic livers preserved 
in IGL-1 + TMZ solution than in IGL-1 and UW solu-
tions (Figure 4A and B). In contrast, the inhibition of  NO 
by L-NAME showed significantly increased in AST/ALT 
release, in both kinds of  liver. In all cases, the AST/ALT 
profiles were consistent with those obtained for HIF-1α 
accumulation during reperfusion (Figure 2).
TMZ also had beneficial effects on bile production 
and %BSP clearance in bile (Figure 4C and D). It also 
promoted a significant reduction in vascular resistance 
(Figure 4E), when compared to IGL-1 and UW solutions. 
The greatest reduction in vascular resistance occurred 
when TMZ was added to IGL-1. This finding is consis-
tent with highest increases in eNOS activity and nitrite/ni-
trate levels as shown in Figures 2 and 3.
Mitochondrial damage was evaluated by measuring 
GLDH activity levels in perfusate at the end of  the reper-
fusion period. Steatotic livers preserved in UW solution 
showed greater GLDH activity than did non-steatotic liv-
ers (Figure 5A). Livers stored in IGL-1 as well as in IGL-1 
+ TMZ solution reduced GLDH levels in both type of  
livers (Figure 5).
Finally, we examined the effect of  HIF-1α accumula-
tion during liver reperfusion on the induction of  other 
cytoprotective agents, such as HO-1. HO-1 expression 
was exacerbated in both kinds of  liver preserved in 
IGL-1 + TMZ solution when compared to IGL-1 and 
UW alone (Figure 5B). As with HIF-1α, HO-1 was in-
hibited by the presence of  L-NAME in both livers. The 
HO-1 pattern profiles were similar to those obtained for 
HIF-1α (Figure 2).
3503 July 28, 2010|Volume 16|Issue 28|WJG|www.wjgnet.com
75
60
45
30
15
0
150
100
50
0
250
200
150
100
50
0
175
150
125
100
75
50
25
0
AL
T 
(U
/L
)
a,c
a,c,e
a
a,c
a,c,e
a
IG
L-
1 
+
 T
M
Z
IG
L-
1
U
W
Co
nt
 1
IG
L-
1 
+
 T
M
Z
IG
L-
1
U
W
Co
nt
 1
Non-steatotic liver
Steatotic liver
AS
T 
(U
/L
)
a,c
a,c,e
a
a,c
a,c,e
a
IG
L-
1 
+
 T
M
Z
IG
L-
1
U
W
Co
nt
 1
IG
L-
1 
+
 T
M
Z
IG
L-
1
U
W
Co
nt
 1
Non-steatotic liver
Steatotic liver
H
IF
-1
α 
( μ
g/
m
g 
pr
ot
ei
n)
a,c
a,c,e
a
a,c
a,c,e
a
IG
L-
1 
+
 T
M
Z
IG
L-
1
U
W
Co
nt
 1
IG
L-
1 
+
 T
M
Z
IG
L-
1
U
W
Co
nt
 1
Non-steatotic liver
Steatotic liver
H
IF
-1
α 
(a
rb
itr
ar
y 
un
its
)
a,c
a,c,e
a
a,c
a,c,e
a
IG
L-
1 
+
 T
M
Z
IG
L-
1
U
W
Co
nt
 1
IG
L-
1 
+
 T
M
Z
IG
L-
1
U
W
Co
nt
 1
Non-steatotic liver
Steatotic liver
β-actin
HIF-1α
IG
L-
1 
+
 T
M
Z
IG
L-
1
U
W
Co
nt
 1
IG
L-
1 
+
 T
M
Z
IG
L-
1
U
W
Co
nt
 1
After cold ischemia
DC
BA
Figure 1  Hypoxia-inducible factor-1α protein levels in liver after 24 h of cold storage. A: Representative Western (top) and densitometric analysis (bottom); B: 
Hypoxia-induced factor-1α (HIF-1α) protein levels quantified by Trans AM HIF-1α kit; Alanine transaminase (ALT) (C) and aspartate transaminase (AST) (D) levels in 
flushing effluent after 24 h of cold storage. University Wisconsin (UW): Liver preserved in UW solution; IGL-1: Liver preserved in IGL-1 solution; IGL-1 + trimetazidine (TMZ) 
(trimetazidine): Liver preserved in IGL-1 solution with TMZ; Cont 1: Liver flushed without cold preservation. aP < 0.05 vs Cont 1; cP < 0.05 vs UW; eP < 0.05 vs IGL-1.
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DISCUSSION
HIF-1 is the main factor involved in the regulation of  
transcriptional responses to hypoxia[32,33]. HIF-1α lev-
els accumulate and trigger an increase in expression of  
genes involved in glycolysis, glucose metabolism, mito-
chondrial function, cell survival and resistance to oxida-
tive stress[20], in response to oxygen deprivation, and dur-
ing organ cold storage. For this reason, we have explored 
new pharmacological strategies to promote the highest 
accumulation of  cytoprotective factors such as HIF-1α 
to protect fatty livers against cold ischemia and reperfu-
sion injury. 
Here, we demonstrate for the first time that signifi-
cant activation of  HIF-1α occurs after 24 h of  cold stor-
age in both types of  liver when TMZ is added to IGL-1 
solution. This improves liver protection, as evidenced by 
the reduction in transaminase levels. This is of  particular 
interest in clinical practice, since numerous pharmaco-
logical strategies that are effective in non-steatotic livers 
may not be useful in the presence of  steatosis[34,35]. These 
results agree with the protective effects observed when 
TMZ was added to UW preservation solution[14,25].
Significant HIF-1α accumulation was also found after 
2 h of  liver reperfusion. This is consistent with the finding 
that mesenchymal stem cells pre-treated with TMZ were 
3504 July 28, 2010|Volume 16|Issue 28|WJG|www.wjgnet.com
Figure 2  Hypoxia-inducible factor-1α, nitrite/nitrate and endothelial nitric oxide synthase. A: Hypoxia-induced factor-1α (HIF-1α) protein levels quantified by 
Trans AM HIF-1α kit after 24 h of cold storage and 120 min of normothermic reperfusion; B: Representative Western blotting of HIF-1α (top) and densitometric analy-
sis (bottom) after 24 h of cold storage and 120 min of normothermic reperfusion; C: Nitrite/nitrate levels after 120 min of normothermic reperfusion; D: Endothelial 
nitric oxide synthase (eNOS) protein levels in liver after 120 min of normothermic reperfusion. Representative Western blotting (top) and densitometric analysis (bot-
tom). Cont 2: Liver flushed and perfused ex vivo without cold preservation; University Wisconsin (UW): Liver preserved in UW solution; IGL-1 + trimetazidine (TMZ) + 
NAME: Liver preserved in IGL-1 solution with TMZ and an nitric oxide synthesis inhibitor, L-NAME. aP < 0.05 vs Cont 2;  cP < 0.05 vs UW;  eP < 0.05 vs IGL-1; gP < 0.05 
vs IGL-1 + TMZ.
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protected against H2O2 induced loss of  cellular viability 
and membrane damage, with a concomitant increases in 
HIF-1α[23]. Similar observations were reported by Jayle 
et al[14] when pig kidneys were subjected to warm ischemia 
reperfusion. 
Cumulative HIF-1α levels contributed to liver protec-
tion but they were abolished by the addition of  L-NAME, 
an inhibitor of  NO synthesis. This demonstrates by the 
first time in fatty liver preservation, the relevance of  
NO in HIF-1α accumulation during normoxic liver re-
perfusion.
NO is an intracellular and/or intercellular and dif-
50 μm 50 μm
IGL-1 + TMZ
IGL-1
UW
Cont 2
IGL-1 + TMZ 
+ NAME
Non-steatotic liver                                                                         Steatotic liver
Figure 3  Endothelial nitric oxide synthase immunohistochemistry in steatotic and non-steatotic livers. Control livers and livers stored in University Wisconsin 
(UW) solution show only a little positivity for endothelial nitric oxide synthase (eNOS), localized typically in a few sinusoidal endothelial cells (arrows). The positivity 
increases when the livers are submitted to cold storage with IGL-1 solution and even more when trimetazidine (TMZ) is added to IGL-1 solution. When TMZ is added 
to IGL solution, some positive Kupffer cells (arrowhead) can be observed also. The addition of L-NAME to IGL-1 + TMZ solution reduced eNOS activity. 
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fusible mediator whose role on hepatic IRI is controver-
sial[28,36-38]. Overall, the important factors in determining 
the beneficial vs harmful effects of  NO are the amount, 
duration, and site of  NO production[39,40]. A low concen-
tration eNOS-derived NO serves to maximize blood per-
fusion, promote cell survival and protect the liver against 
IRI[41]. However, a sustained presence of  iNOS-derived 
NO might become detrimental by increasing toxic reactive 
oxygen species leading to liver injury[37,40-42]. The results 
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Figure 4  Alanine transaminase (A), Aspartate transaminase (B) levels in perfusate, bile flow (C), percentage of sulfobromophthalein in bile (D), and vascu-
lar resistance (E) of steatotic and non-steatotic livers after 120 min of normothermic reperfusion. aP < 0.05 vs Cont 2; cP < 0.05 vs University Wisconsin (UW); 
eP < 0.05 vs IGL-1; gP < 0.05 vs IGL-1 + trimetazidine (TMZ). BSP: Sulfobromophthalein; ALT: Alanine transaminase; AST: Aspartate transaminase.
reported here show that the NO benefits were derived 
mainly from eNOS and that they did not originate from 
iNOS activation (data not shown). 
NO vasodilator properties prevent the alterations of  
microcirculation observed during liver reperfusion, which 
are exacerbated in the presence of  steatosis[12,28]. The ad-
dition of  NO donors to UW solution preserves livers 
against cold ischemic injury[13]. Thus, the benefits of  the 
use of  IGL-1 solution for fatty liver preservation are as-
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sociated with the capacity of  generating NO[12]. However, 
the relevance of  NO and it relationship with HIF-1α 
accumulation for increasing fatty liver graft protection 
against cold IRI is demonstrated here for the first time.
In recent years, there has been increasing interest in 
the relationship between HIF-1α and NO. NO profound-
ly affects the HIF-1α signaling pathway[43,44]. In normoxia, 
NO inhibits the prolyl-hydroxylases responsible for HIF-
1α degradation, thus contributing to its stability[17].
Our results demonstrate that HIF-1α also accumulate 
during reperfusion in the presence of  NO in liver grafts 
preserved in IGL-1 + TMZ or IGL-1 alone. Beneficial 
effects on HIF-1α accumulation are confirmed by the 
increased constitutive eNOS activity and nitrite/nitrate 
levels in liver grafts preserved in both solutions. In ad-
dition, these data confirm the synergism between IGL-1 
solution and TMZ, responsible for the increased NO 
production by the activation of  constitutive eNOS[24,28]. 
NO levels generated from the synergistic action of  TMZ 
in IGL-1 solution are determinant of  effective HIF-
1α accumulation and subsequent protection of  the liver 
graft against IRI. This differs from the effects observed 
when TMZ was added to UW, where the induction of  
eNOS activity was lower (data not shown). 
Previous studies from our group showed that bile 
production is higher when livers are preserved in IGL-
1than when they are preserved in UW[12]. Similarly, TMZ 
increased bile secretion when added to UW solution[25]. 
Our results show a synergistic action when TMZ is added 
to IGL-1 solution, which enhances the increase in bile 
production.
Fat accumulation in the cytoplasm of  the hepatocytes 
is associated with an increase in cell volume, which may 
result in the partial or complete obstruction of  the hepatic 
sinusoidal space[45,46]. Our results demonstrate that NO 
generated from the synergistic action mentioned above 
contributes to the reduction in vascular resistance. In fact 
NO inhibition by L-NAME increased vascular resistance, 
confirming the role of  NO in fatty liver preservation.
Fatty degeneration, which induces a series of  ultra-
structural and biochemical alterations in mitochondria[47,48] 
may render these organelles intrinsically more susceptible 
to I/R injury. Mitochondrial injury is a common pathway 
of  cell necrosis and apoptosis in IRI. Recent studies have 
shown that activation of  HIF-1α prevents mitochon-
drial injury after mouse liver ischemia reperfusion[49]. Our 
results indicate that the HIF-1α accumulation after nor-
moxic reperfusion prevented mitochondrial injury.
 Finally, we measured the expression of  HO-1 after 2 h 
of  normothermic reperfusion, as a potential gene target 
induced by HIF-1α activation[18,19]. HO-1 is activated 
during cellular stress: its over-expression is a requisite for 
increasing organ cytoprotection against IRI, especially 
when steatosis is present[20,21,45,50].
We confirmed increased HO-1 expression in livers 
preserved in IGL-1 and IGL-1 + TMZ solutions. This 
is in line with the better protection against reperfusion 
injury in livers stored in IGL-1 + TMZ solution than in 
IGL-1 or UW alone. The abolition of  HIF-1α stabiliza-
tion by NO inhibition with L-NAME reversed HO-1 
levels and increased liver injury after reperfusion.
In conclusion, we report by the first time the impor-
tance of  NO in fatty liver reperfusion in stabilizing HIF-
1α which is generated during liver cold storage.HIF-1α 
accumulation determines, in part, the increase in HO-1, 
a cytoprotective factor which improves the outcome of  
grafts after transplantation.
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Figure 5  Glutamate dehydrogenase and heme oxygenase-1. A: Glutamate 
dehydrogenase (GLDH) levels after 120 min of reperfusion; B: Heme oxygen-
ase-1 (HO-1) protein levels in liver after 120 min of normothermic reperfusion. 
Representative Western blotting at (top) and densitometric analysis at (bottom). 
aP < 0.05 vs Cont 2; cP < 0.05 vs University Wisconsin (UW); eP < 0.05 vs IGL-1; 
gP < 0.05 vs IGL-1 + trimetazidine (TMZ).
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Background
Steatosis is a major risk against cold ischemia-reperfusion injury (IRI). Hypoxia 
inducible factor-1α (HIF-1α) is a cytoprotective factor generated in response to 
lack of oxygen, as occurs during cold storage of liver grafts in preservation solu-
tions. IGL-1 solution has been proposed as an effective alternative to University 
Wisconsin for steatotic liver preservation. The benefits of IGL-1 solution are due 
in part to its capacity to increase the levels of nitric oxide (NO).
Research frontiers
NO impairs normoxic degradation of HIF-1α by inhibition of prolyl-hydroxylases 
and contributes to its stabilization. HIF-1α confers protection against IRI by 
activating genes such as heme oxygenase-1 which plays an important cytopro-
tective role in liver graft preservation against cold IRI. In this study, the authors 
focused on the importance of HIF-1α and NO in fatty liver preservation.
Innovations and breakthroughs
The authors provide evidence that the enrichment of IGL-1 solution with trimeta-
zidine (an anti-ischemic drug) increases NO generation and prevents HIF-1α 
degradation during steatotic liver graft reperfusion.
Applications
The use of modified IGL-1 solutions should be a useful strategy for increasing 
steatotic liver graft preservation through HIF-1α accumulation in normothermic 
reperfusion.
Peer review
In essence, the paper demonstrates that the HIF/NO system is important in 
fatty liver preservation following ischemia reperfusion injury. The study is well 
designed and the interpretation of the data is adequate.
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